Relating Guidance to Process Control and an overarching “Quality Management System”

It is easy to think of how a QMS functions and is implemented as simply the natural outcome of necessary compliance to the existing guidance. This tendency creeps into our heads the longer we work in this industry - some new guidance is updated so we tweak and edit the QMS to reflect the changed expectations.

Too often we think of the pharmaceutical quality management system as several core process and procedures, such as:

  • Document management

  • Change control

  • Training management

  • Audit management

  • CAPA management

  • Deviation management

This has a danger or relegating QMS ownership to the quality assurance department alone.

This “compliance led” view of PQS is actually quite limiting in its scope and can lead companies (and individuals) to think a PQS is simply a list of things “we have to do” as opposed to a tool that when used correctly will enhance technical product quality, ensure product delivery and ensure compliance as a side effect.

Enabling Process Control

A mental model I find more helpful is to relate QMS activities to overall maintaining a state of control and the necessary feedback loops to make it work. For now I am not going to expand into Statistical Process Control. Starting to talk SPC without first laying some groundwork causes many people to run in fear of integrals and excel functions.

Below is a simple quality management process control model adapted from the automotive industry. If you don’t think its relevant just remember that automotive companies also build products that if made incorrectly have the potential to kill or maim their customers, are in a highly regulated market with margins that are tighter than they would like. We can lead excellent quality management thinking from others…..

The general principle resolves around some fundamental practices that are identical to how we manage pharmaceutical operations.

  • Inputs are subject to specific control requirements

  • We undertake a core group of manufacturing a testing procedures that take our inputs and add value.

  • We product a product or service for customer use.

  • We obtain feedback information to enable control and improvement from both within our organisation (Voice of the process) and from outside the organisation (Voice of the customer).

To take this further it is possible to map almost all pharmaceutical GMP guidance to the process model elements above. For example (not exhaustively):

People - Chapter 1/2, Annex 16, Annex 13

Equipment - Chapter 3/5, Annex 1/3/11

Material - Chapter 5/6, Annex 8

Method - Annex 1/2/3/4/5/6/7/9/10/12/13/14/15

Measurement - Chapter 6, Pharmacopeia’s, Annex 17/19

Environment - Chapter 3, Chapter 5, Annex 1

Value added activity - Chapter 45/6/7, Annex 15/21

Voice of the process - Chapter 1 (Specifically Product Quality Reviews) & Chapter 9 (Self Inspection), ICH Q9

Voice of the Customer - Chapter 8 (Complaints and Recalls), MAs and Variations

Once we understand how all these activities interlink its then possible to see how we can use existing quality assurance approaches (including those from other industries) to bring the process into a state of control, practically and statistically.

To be continued.

Click here to return to the training notes index

Disclaimer

This document is not a legal document not should it be interpreted in any fashion as a guide. This is a set of notes compiled as part of a personal CPD program.  It is not complete or authoritative. I hope it gives you some value.

This is a personal effort and is not affiliated with my current role or employer.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. If you use it to train someone else, fantastic, but give the QP Notebook a plug. Thanks